foxo4-dri senolytic mechanism Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Class II senolytics inhibit survival
Class II senolytics inhibit survival pathways elicited by senescent Download Scientific Diagram Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 10mg Vial Buy Online Crystal Peptides Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOX04 DRI (10mg) Nordsci
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



